Tim Nuttall

Tim Nuttall

Auto-generated profile, based on publicly available information

Tim Nuttall

Royal (Dick) School of Veterinary Studies, University of Edinburgh

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2002 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
PDF file
TNT. J. Nuttall
T. J. Nuttall
PKP. A. Knight
P. A. Knight
SMS. M. McAleese
S. M. McAleese
JLJ. R. Lamb
J. R. Lamb
PHP. B. Hill
P. B. Hill

9 February 2013 in Veterinary Record
Verified
Journal Article
Open access
PDF file
LBL. Beco
L. Beco
EGE. Guaguère
E. Guaguère
CMC. Lorente Méndez
C. Lorente Méndez
CNC. Noli
C. Noli
TNT. Nuttall
T. Nuttall
MVM. Vroom
M. Vroom
Systemic antimicrobials are critically important in veterinary healthcare, and resistance is a major concern. Antimicrobial stewardship will be important in maintaining clinical efficacy by reducing the development and spread of antimicrobial resistance. Bacterial skin infections are one of the most common reasons for using systemic antimicrobials in dogs and cats. Appropriate management of these infections is, therefore, crucial in any policy for responsible antimicrobial use. The goals of therapy are to confirm that an infection is present, identify the causative bacteria, select the most appropriate antimicrobial, ensure that the infection is treated correctly, and to identify and manage any underlying conditions. This is the second of two articles that provide evidence‐led guidelines to help practitioners address these issues. Part 1 discussed the use of clinical signs, cytology and culture in diagnosis. This article will cover the rationale for topical and systemic antimicrobial therapy, including choice of first‐, second‐ and third‐line drugs, the dose, duration of therapy, compliance and identification of underlying predisposing conditions. In addition, there is guidance on cases of therapeutic failure and environmental hygiene. These guidelines will help veterinarians avoid the development and propagation of antimicrobial‐resistant bacterial strains.

21 January 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
LNLogan Newstead
Logan Newstead
KVKatarina Varjonen
Katarina Varjonen
TNTim Nuttall
Tim Nuttall
GPGavin Paterson
Gavin Paterson
Staphylococcus aureus is an important pathogen of both humans and animals, implicated in a wide range of infections. The emergence of antibiotic resistance has resulted in S. aureus strains that are resistant to almost all available antibiotics, making treatment a clinical challenge. Development of novel antimicrobial approaches is now a priority worldwide. Bacteria produce a range of antimicrobial peptides; the most diverse of these being bacteriocins. Bacteriocins are ribosomally synthesised peptides, displaying potent antimicrobial activity usually against bacteria phylogenetically related to the producer strain. Several bacteriocins have been isolated from commensal coagulase-negative staphylococci, many of which display inhibitory activity against S. aureus in vitro and in vivo. The ability of these bacteriocins to target biofilm formation and their novel mechanisms of action with efficacy against antibiotic-resistant bacteria make them strong candidates as novel therapeutic antimicrobials. The use of genome-mining tools will help to advance identification and classification of bacteriocins. This review discusses the staphylococcal-derived antimicrobial peptides displaying promise as novel treatments for S. aureus infections.

6 August 2014 in Veterinary Dermatology
Verified
Journal Article
Closed access
PDF file
TNTim Nuttall
Tim Nuttall
EBEmmanuel Bensignor
Emmanuel Bensignor

29 April 2016 in In Practice
Verified
Journal Article
Open access
PDF file
TNTim Nuttall
Tim Nuttall
Otitis is one the most common problems seen in dogs. Most acute cases can be managed with topical polyvalent ear preparations. However, these cases frequently evolve into chronic or recurrent otitis that is much harder to resolve. Ongoing cycles of infection and inflammation will lead to chronic pathological changes and select for antimicrobial resistance that make management much more challenging. Diagnosis and management of the underlying triggers for the otitis is crucial, but clinicians must also understand how best to treat the ongoing infection and inflammation. Knowing how to recognise and understanding the significance of biofilms is important, as these are under diagnosed and have a major impact on antimicrobial efficacy. Cytology should be performed in all cases to determine the type of infection and the likely nature of the micro‐organisms. Bacterial culture and antimicrobial susceptibility, in contrast, are less useful. The tests are based on systemic treatment, and vets need to know how to interpret the results when using topical treatment. Topical therapy is generally much more effective, and there are a very wide range of anti‐microbial and anti‐inflammatory options available (although not all are licensed for use in animals). Long‐term remission of recurrent otitis relies on managing the inflammation in the ear canals to prevent flares. Getting clients to understand this is critical. Choosing appropriate products and demonstrating how to apply them are also important in ensuring good compliance and a good long term outcome.

18 May 2009 in Veterinary Dermatology
Verified
Journal Article
Closed access
PDF file
TNTim Nuttall
Tim Nuttall
RMRalf Mueller
Ralf Mueller
EBEmmanuel Bensignor
Emmanuel Bensignor
MVMaite Verde
Maite Verde
CNChiara Noli
Chiara Noli
CRChristophe Rème
Christophe Rème